Jupiter Life Line Hospitals Limited

Jupiter Life Line Hospitals Limited (JLHL) is a small-cap Healthcare company valued at ₹8,102 crore operating in Hospital on the NSE and BSE.

Recent price move

Jupiter Life Line Hospitals Limited last traded at ₹247.25, up 3.17% on the day.

Recent developments

2026-07-31: Jupiter Life Line Hospitals Limited announced an acquisition, including an agreement to acquire, which may expand its healthcare services in the Mumbai Metropolitan Area and western region of India.

Financial performance

The company's annual revenue grew 15.2% to ₹1,500 crore, while annual net profit rose 2.6% to ₹199 crore. However, the net profit margin narrowed 1.6 percentage points to 13.3%, and the latest quarter showed a decline in net profit by 14.8% despite a 16.4% increase in revenue.

Valuation multiples

The stock trades at 41.8 times earnings, a premium to the Healthcare median of 32.0, 5.96 times book value. It yields 0.4%.

Things to watch

The company's net profit margin has narrowed, and the latest quarter's net profit fell 14.8% compared to the same quarter a year earlier. The stock is 23.6% below its 52-week high, and domestic institutional holdings decreased by 0.50 percentage points in the quarter.

Where it stands

Jupiter Life Line Hospitals Limited reported a 15.2% annual revenue growth and a 2.6% rise in net profit, but the net profit margin declined. The company's recent acquisition may signal expansion, but the stock is trading below its 52-week high. The latest quarter's net profit dropped 14.8%, which is the most significant movement in its financials.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.